Bailard’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.4M | Buy |
28,935
+1,199
| +4% | +$57.9K | 0.03% | 280 |
|
|
2025
Q1 | $1.54M | Buy |
27,736
+11,377
| +70% | +$631K | 0.04% | 249 |
|
|
2024
Q4 | $789K | Buy |
16,359
+220
| +1% | +$10.6K | 0.02% | 340 |
|
|
2024
Q3 | $930K | Buy |
16,139
+173
| +1% | +$9.97K | 0.02% | 319 |
|
|
2024
Q2 | $775K | Sell |
15,966
-533
| -3% | -$25.9K | 0.02% | 338 |
|
|
2024
Q1 | $802K | Buy |
16,499
+1,232
| +8% | +$59.9K | 0.02% | 340 |
|
|
2023
Q4 | $759K | Sell |
15,267
-346
| -2% | -$17.2K | 0.02% | 342 |
|
|
2023
Q3 | $837K | Sell |
15,613
-1,356
| -8% | -$72.7K | 0.03% | 296 |
|
|
2023
Q2 | $915K | Buy |
16,969
+23
| +0.1% | +$1.24K | 0.03% | 278 |
|
|
2023
Q1 | $922K | Buy |
16,946
+1,455
| +9% | +$79.2K | 0.03% | 279 |
|
|
2022
Q4 | $750K | Buy |
15,491
+1,814
| +13% | +$87.9K | 0.03% | 307 |
|
|
2022
Q3 | $520K | Sell |
13,677
-1,332
| -9% | -$50.6K | 0.02% | 358 |
|
|
2022
Q2 | $751K | Buy |
15,009
+341
| +2% | +$17.1K | 0.03% | 284 |
|
|
2022
Q1 | $753K | Sell |
14,668
-24
| -0.2% | -$1.23K | 0.03% | 323 |
|
|
2021
Q4 | $736K | Sell |
14,692
-1,289
| -8% | -$64.6K | 0.02% | 325 |
|
|
2021
Q3 | $770K | Buy |
15,981
+543
| +4% | +$26.2K | 0.03% | 313 |
|
|
2021
Q2 | $813K | Buy |
15,438
+568
| +4% | +$29.9K | 0.03% | 308 |
|
|
2021
Q1 | $735K | Buy |
14,870
+1,084
| +8% | +$53.6K | 0.03% | 307 |
|
|
2020
Q4 | $670K | Buy |
13,786
+1,689
| +14% | +$82.1K | 0.03% | 264 |
|
|
2020
Q3 | $607K | Buy |
12,097
+380
| +3% | +$19.1K | 0.03% | 260 |
|
|
2020
Q2 | $598K | Buy |
11,717
+1,188
| +11% | +$60.6K | 0.03% | 251 |
|
|
2020
Q1 | $460K | Buy |
+10,529
| New | +$460K | 0.03% | 239 |
|